Skip to content
Averica
Speeding Discovery into Development
  • Services
    • Chiral Separation
    • Pharmaceutical Impurities
      • Nitrosamines Impurities Testing for Pharmaceuticals
      • Extractables and Leachables Testing
      • PFAS Testing
    • HPLC Method Development & Validation
    • Experimental Polar Surface Area (EPSA)
    • Physical Properties
    • GMP Testing
  • About Us
    • Technology
    • Testimonials
    • Careers
  • Resources
    • Events
    • Webinars
    • Blog
  • Blog
  • Contact Us
  • Twitter LinkedIn
Averica logo blue
Most Popular
Explore

Most Popular articles

Mass Balance – What, When, How?

Why Thalidomide is Important to Chiral Separation

Understanding the Importance of Stress Degradation Studies

EPSA: A New Bioavailability / Permeability Assay

Developing and Validating an HPLC Method – Averica

Lab tubes

Chiral (15)

Purification (11)

Method Developmemt (14)

Averica Impurity Isolation

impurities (14)

Averica Thalidomide

GMP (7)

Physical Chemistry Property (3)

General (18)

  • Services
    • Chiral Separation
    • HPLC Method Development & Validation
    • Pharmaceutical Impurities
    • Physical Properties
    • GMP Testing
  • Contact Us
  • Events
  • About Us
  • Technology
  • Careers
  • Testimonials
Twitter LinkedIn
Neopharm Labs Acquires Averica
455 Fortune Boulevard, Suite 2, Milford, MA 01757 | Phone: 508-757-4600 | sales@avericadiscovery.com
© 2023 | Averica Discovery Services Inc.